Anemia is a condition in which there is a decrease in the number of red blood cells or hemoglobin in the blood.
贫血是一种血液中红细胞或血红蛋白含量减少的状况。
Iron deficiency
anemia is the most common type, caused by insufficient iron in the body.
铁缺乏性贫血是最常见的类型，由体内铁元素不足引起。
Symptoms of
anemia can include fatigue, weakness, and shortness of breath.
贫血的症状可能包括疲劳、虚弱和呼吸短促。
The doctor recommended a blood test to check for
anemia after discussing the patient's symptoms.
在讨论了患者的症状后，医生建议进行血液检查以检查贫血情况。
Pregnant women are at a higher risk of developing
anemia due to increased demands for iron and other nutrients.
孕妇因对铁和其他营养素的需求增加，有更高的风险患贫血。
Treatment for
anemia often involves supplementing with iron, vitamins, or in severe cases, blood transfusions.
贫血的治疗通常包括补充铁剂、维生素，严重时可能需要输血。
Chronic diseases such as kidney disease and cancer can also lead to
anemia.
慢性疾病，如肾脏疾病和癌症，也可能导致贫血。
A balanced diet rich in iron, folate, and vitamin B12 can help prevent certain types of
anemia.
富含铁、叶酸和维生素B12的均衡饮食有助于预防某些类型的贫血。
Anemia can sometimes be an indicator of underlying health issues and warrants further medical investigation.
贫血有时可能是潜在健康问题的指示器，需要进一步的医学检查。
In children,
anemia can impair growth and cognitive development, making early detection and treatment crucial.
儿童贫血可影响生长和认知发展，因此早期发现和治疗至关重要。
Pharmacosmos A/S, a Denmark-based industry leader for developing and marketing medicines for the treatment of iron deficiency, said its Monofer, a new generation of innovative intravenous iron for the treatment of iron deficiency and iron-deficiency anemia, will soon be officially available to Chinese patients.
丹麦医药公司Pharmacosmos A/S宣布，其研发的新一代创新静脉注射铁剂Monofer将很快正式在中国上市，用于治疗铁缺乏和缺铁性贫血。作为该领域的行业领导者，Pharmacosmos致力于开发和推广铁剂药物。
The drug was the first innovative intravenous iron approved in China since 2005, when the National Medical Products Administration approved it in February for the treatment of iron deficiency and iron-deficiency anemia in adult patients who have an intolerance to oral iron, have had an unsatisfactory response to oral iron, or when there is a clinical need to deliver iron rapidly.
这款药物是自2005年以来中国批准的首款创新静脉注射铁剂。今年2月，国家药品监督管理局将其批准用于治疗对口服铁不耐受、对口服铁反应不佳，或有临床需求快速补铁的成年患者所患的缺铁症和缺铁性贫血。
The drug also is expected to expand the use of IV iron across multiple therapeutic areas in China, as iron-deficient anemia is a frequent condition for patients across various therapeutic areas.
该药物也有望扩大静脉铁剂在中国多个治疗领域的应用，因为缺铁性贫血是各种治疗领域患者常见的情况。
The Chinese market of intravenous iron for the treatment of iron deficiency and iron deficiency anemia is one of the largest in the world, with a general prevalence of about 20 percent among Chinese, some research showed.
中国是全球最大的静脉铁剂治疗缺铁和缺铁性贫血的市场之一，据一些研究显示，中国人的普遍患病率约为20%。
Chinese biotech company EdiGene Inc announced on Monday the Center for Drug Evaluation of the China National Medical Products Administration has approved the company's Investigational New Drug application for ET-01, a CRISPR/Cas 9 gene-editing therapy for patients with transfusion dependent β-thalassemia, a blood disease characterized by severe anemia and a lifelong dependence on red blood cell transfusions that can lead to iron overload.
中国生物技术公司EdiGene周一宣布，中国国家药品监督管理局药品审评中心已批准其ET-01的新药临床试验申请。ET-01是一种使用CRISPR/Cas9基因编辑技术治疗输血依赖性β地中海贫血症的疗法。该疾病是一种以严重贫血和终身依赖红细胞输血为特征的血液病，可能导致铁过载。
But the development of therapeutic CD47 antibodies has been hampered by hematologic side-effects, such as severe anemia, because of the binding of CD47 on red blood cells.
AstraZeneca China announced on Tuesday that new anemia drug roxadustat has received approval from the National Medical Products Administration.
China has become the first country worldwide to approve the oral anemia treatment hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI).
According to the NMPA approval, roxadustat is to be used in the treatment of anemia caused by chronic kidney disease (CKD) in patients who are dialysis-dependent (DD).
There are over 120 million CKD patients in China, and anemia is one of the complications of CKD, occurring at a rate of up to 98.2 percent in patients on dialysis, according to medical journals Lancet and Chinese Journal of Nephrology.
未经许可，严禁转发。QQ交流群：688169419